Key Highlights:
Investments of over $200 million in the Owensboro factory in Kentucky, USA, have created hundreds of job opportunities.
The factory produces ZYN nicotine pouches under its parent company, Philip Morris International (PMI). The expansion plan will ultimately create or exceed 450 jobs.
This investment is expected to bring $277 million in revenue to the local area each year, with the expansion project projected to be completed in June.
According to Tristatehomepage's report on April 1st, the CEO of Swedish Match discussed expansion plans in Owensboro, Kentucky. Governor Andy Beshear announced an investment of over $200 million in the factory in the fall of 2024. Officials also discussed the potential job opportunities for the local community and how FDA approval will drive the expansion of the company's products this year.
Six months ago, Governor Andy Beshear announced a $232 million investment in the Owensboro, Kentucky match factory, expected to bring over 450 jobs. The factory produces ZYN nicotine pouches for its parent company, Philip Morris International (PMI). Stacey Kennedy, President and CEO of PMI's Americas region, stated that around 370 jobs have already been added, with expectations to reach or exceed the 450 job target in the future.
This investment has helped the city enter the top ten of the fastest-growing economies in the United States, while also expected to bring in $277 million in revenue for the city each year.
Kennedy claims that the factory is the flagship factory ranked number one globally, with expansion projects expected to be completed in June.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
